Johnson & Johnson has struck a $13.1 billion deal to buy Shockwave Medical, extending its position in devices that treat heart disease.
Wall Street Journal
Johnson & Johnson has struck a $13.1 billion deal to buy Shockwave Medical, extending its position in devices that treat heart disease.